Search

everythinglearnresearchcommunity

for

Search:↓

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Early intervention and patient education are crucial for managing alopecia areata.

Photobiomodulation therapy shows promise in treating various health conditions by using specific light wavelengths.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Skin problems are very common in people with systemic lupus erythematosus and important for diagnosis.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Different types of facial fat affect aging and treatment outcomes; more research is needed to enhance anti-aging procedures.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Lupus can cause hair loss and nail changes, with treatments available for both.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.